Cash & equivalents increased 87.1%
Cash & equivalents changed +87.1% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +87.1% from the comparable as-filed period.
Net income changed -180.9% from the comparable as-filed period.
Operating income changed +510.6% from the comparable as-filed period.
Operating margin changed +1490 basis points from the comparable as-filed period.
Research & development changed -28.0% from the comparable as-filed period.
Selling, general & administrative changed -35.5% from the comparable as-filed period.
Gross margin changed -110 basis points from the comparable as-filed period.
Gross profit changed -5.3% from the comparable as-filed period.
Inventory changed -6.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed -5.4% from the comparable as-filed period.
Debt changed -2.4% from the comparable as-filed period.
Revenue changed -3.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.